Erratum: An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome (Cancer Causes Control DOI:10.1007/s10552-012-0018-7);An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome

Cancer Causes and Control

Volumn 23, Issue 9, 2012, Pages 1443-1449

  Anic, Gabriella M ^a   Thompson, Reid C ^b   Nabors, L Burton ^c   Olson, Jeffrey J ^d   Browning, James E ^a   Madden, Melissa H ^a   Murtagh, F Reed ^a   Forsyth, Peter A ^a   Egan, Kathleen M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genotype; Glioma; Single nucleotide polymorphism; VDR; Vitamin D

Indexed keywords

VITAMIN D; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; C10ORF88 GENE; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; CYP24A1 GENE; CYP2R1 GENE; FEMALE; GC GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLIOMA; HETEROZYGOTE; HISTOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NADSYN1 GENE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VDR GENE; VITAMIN BLOOD LEVEL;

EID: 84864886286     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0044-5     Document Type: Erratum

References (27)

1. Hansen CM, Binderup L, Hamberg KJ, Carlberg C (2001) Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 6:D820-D848
2. Garland CF, Gorham ED, Mohr SB et al (2007) Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103:708-711
3. Touvier M, Chan DS, Lau R et al (2011) Meta-analyses of vitamin d intake, 25-hydroxyvitamin d status, vitamin d receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20:1003-1016
4. Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99:1594-1602
5. Giovannucci E, Vitamin D (2009) and cancer incidence in the Harvard cohorts. Ann Epidemiol 19:84-88
6. Helzlsouer KJ (2010) Overview of the cohort consortium Vitamin D pooling project of rarer cancers. Am J Epidemiol 172:4-9
7. Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-459
8. Mohr SB, Gorham ED, Garland CF, Grant WB, Garland FC (2010) Low ultraviolet B and increased risk of brain cancer: an ecological study of 175 countries. Neuroepidemiology 35:281-290
9. Elias J, Marian B, Edling C et al (2003) Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res 164:319-332
10. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29:21-30
11. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143-156
12. Fang Y, van Meurs JB, d'Alesio A et al (2005) Promoter and 30-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet 77:807-823
13. Wang TJ, Zhang F, Richards JB et al (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180-188
14. Ahn J, Yu K, Stolzenberg-Solomon R et al (2010) Genome-wide association study of circulating Vitamin D levels. Hum Mol Genet 19:2739-2745
15. Egan KM, Thompson RC, Nabors LB, et al. (2011) Cancer susceptibility variants and the risk of adult glioma in a US casecontrol study. J Neurooncol
16. Permuth-Wey J, Thompson RC, Burton Nabors L et al (2011) A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol 105: 639-646
17. Shete S, Hosking FJ, Robertson LB et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899-904
18. Wrensch M, Jenkins RB, Chang JS et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905-908
19. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068
20. Whitfield GK, Remus LS, Jurutka PW et al (2001) Functionally relevant polymorphisms in the human nuclear Vitamin D receptor gene. Mol Cell Endocrinol 177:145-159
21. Denzer N, Vogt T, Reichrath J (2011) Vitamin D receptor (VDR) polymorphisms and skin cancer: a systematic review. Dermatoendocrinol 3:205-210
22. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29:3511-3536
23. McCullough ML, Bostick RM, Mayo TL (2009) Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 29:111-132
24. McKay JD, McCullough ML, Ziegler RG et al (2009) Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 18:297-305
25. Davies JR, Chang YM, Snowden H et al (2011) The determinants of serum vitamin D levels in participants in a melanoma casecontrol study living in a temperate climate. Cancer Causes Control 22:1471-1482
26. Simon KC, Munger KL, Kraft P, Hunter DJ, De Jager PL, Ascherio A (2011) Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Neurol 258:1676-1682
27. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109